PatientsVille.com Logo

Chloroquine Side Effects

PatientsVille

Common Chloroquine Side Effects


The most commonly reported Chloroquine side effects (click to view or check a box to report):

Atrioventricular Block Complete (25)
Mania (15)
Electrocardiogram Qrs Complex Prolonged (13)
Cardiac Arrest (13)
Cardiac Failure Congestive (12)
Electrocardiogram Qt Prolonged (11)
Dizziness (11)
Muscular Weakness (10)
Cardiomyopathy (10)
Cardiotoxicity (10)
Overdose (10)
Toxicity To Various Agents (10)
Ventricular Fibrillation (10)
Cardiogenic Shock (9)
Loss Of Consciousness (9)
Abdominal Pain (9)
Insomnia (8)
Psychotic Disorder (8)
Syncope (8)
Torsade De Pointes (8)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Chloroquine Side Effects Reported to FDA



Chloroquine Side Effect Report#9972266
Systemic Lupus Erythematosus, Psychomotor Retardation, Feelings Of Worthlessness, Decreased Interest, Agitation, Suicidal Ideation, Major Depression, Blood Cholesterol Increased, Low Density Lipoprotein Increased
This is a report of a 31-year-old male patient (weight: NA) from PL, suffering from the following health symptoms/conditions: systemic lupus erythematosus, who was treated with Chloroquine (dosage: NA, start time: NS), combined with:
  • Methylprednisolone
  • Sulpiride
  • Quetiapine
  • Lamotrigine
and developed a serious reaction and side effect(s): Systemic Lupus Erythematosus, Psychomotor Retardation, Feelings Of Worthlessness, Decreased Interest, Agitation, Suicidal Ideation, Major Depression, Blood Cholesterol Increased, Low Density Lipoprotein Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Chloroquine treatment in male patients, resulting in Systemic Lupus Erythematosus side effect. The patient was hospitalized.
Chloroquine Side Effect Report#9958695
Suicidal Ideation, Major Depression, Low Density Lipoprotein Increased, Blood Cholesterol Increased, Platelet Count Decreased, Mania, Bipolar Disorder, Condition Aggravated
This report suggests a potential Chloroquine Suicidal Ideation side effect(s) that can have serious consequences. A 31-year-old male patient (weight: NA) from PL was diagnosed with the following symptoms/conditions: systemic lupus erythematosus and used Chloroquine (dosage: (125 Mg Bid), (250 Mg, Daily)) starting NS. After starting Chloroquine the patient began experiencing various side effects, including: Suicidal Ideation, Major Depression, Low Density Lipoprotein Increased, Blood Cholesterol Increased, Platelet Count Decreased, Mania, Bipolar Disorder, Condition AggravatedAdditional drugs used concurrently:
  • Methlyprednisolone
  • Perazine
  • Mirtazapine
  • Hydroxyzine
  • Hydroxychloroquine
  • Quetiapine
  • Lamotrigine
  • Clorazepate Dipotassium
The patient was hospitalized. Although Chloroquine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Suicidal Ideation, may still occur.
Chloroquine Side Effect Report#9917618
Completed Suicide, Toxicity To Various Agents, Fluid Overload, Pulmonary Congestion, Cardiac Failure Congestive, Flatulence
This Completed Suicide problem was reported by a health professional from CH. A 25-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Chloroquine (dosage: NA). The following drugs were being taken at the same time:
  • Diazepam
When using Chloroquine, the patient experienced the following unwanted symptoms/side effects: Completed Suicide, Toxicity To Various Agents, Fluid Overload, Pulmonary Congestion, Cardiac Failure Congestive, FlatulenceAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Completed Suicide, may become evident only after a product is in use by the general population.
Chloroquine Side Effect Report#9885984
Cytotoxic Cardiomyopathy, Myopathy Toxic, Cardio-respiratory Arrest, Atrioventricular Block Complete, Cardiac Failure Congestive, Syncope
This Cytotoxic Cardiomyopathy side effect was reported by a physician from US. A 38-year-old female patient (weight:NA) experienced the following symptoms/conditions: cutaneous lupus erythematosus.The patient was prescribed Chloroquine (watson Laboratories) (drug dosage: 500 Mg, Daily), which was initiated on NS. Concurrently used drugs: NA..After starting to take Chloroquine (watson Laboratories) the consumer reported adverse symptoms, such as: Cytotoxic Cardiomyopathy, Myopathy Toxic, Cardio-respiratory Arrest, Atrioventricular Block Complete, Cardiac Failure Congestive, SyncopeThese side effects may potentially be related to Chloroquine (watson Laboratories). The patient was hospitalized.
Chloroquine Side Effect Report#9870747
Poisoning, Completed Suicide
This is a report of a 25-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: NA, who was treated with Chloroquine (dosage: Df, Oral, start time: NS), combined with:
  • Alprazolam (Df, Oral)
  • Zolpidem (Df Oral)
  • Diphenhydramine (Df Oral)
  • Mirtazapine (Df Oral)
and developed a serious reaction and side effect(s): Poisoning, Completed Suicide after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Chloroquine treatment in female patients, resulting in Poisoning side effect.
Chloroquine Side Effect Report#9858419
Bipolar Disorder, Depression, Psychotic Disorder, Mania, Feelings Of Worthlessness, Psychomotor Retardation, Negative Thoughts, Decreased Interest, Agitation
This report suggests a potential Chloroquine (salt Not Specified) Bipolar Disorder side effect(s) that can have serious consequences. A 31-year-old male patient (weight: NA) from PL was diagnosed with the following symptoms/conditions: systemic lupus erythematosus and used Chloroquine (salt Not Specified) (dosage: NA) starting NS. After starting Chloroquine (salt Not Specified) the patient began experiencing various side effects, including: Bipolar Disorder, Depression, Psychotic Disorder, Mania, Feelings Of Worthlessness, Psychomotor Retardation, Negative Thoughts, Decreased Interest, AgitationAdditional drugs used concurrently: NA.The patient was hospitalized. Although Chloroquine (salt Not Specified) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Bipolar Disorder, may still occur.
Chloroquine Side Effect Report#9813644
Toxicity To Various Agents
This Toxicity To Various Agents problem was reported by a pharmacist from US. A 25-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Chloroquine (dosage: NA). The following drugs were being taken at the same time:
  • Diphenhydramine Hydrochloride
  • Alprazolam
  • Zolpidem
  • Mirtazapine
When using Chloroquine, the patient experienced the following unwanted symptoms/side effects: Toxicity To Various AgentsAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Toxicity To Various Agents, may become evident only after a product is in use by the general population.
Chloroquine Side Effect Report#9785791
Bipolar Disorder, Major Depression, Mania, Suicidal Ideation, Systemic Lupus Erythematosus, Psychomotor Retardation, Feelings Of Worthlessness, Decreased Interest
This Bipolar Disorder side effect was reported by a health professional from PL. A 31-year-old male patient (weight:NA) experienced the following symptoms/conditions: systemic lupus erythematosus.The patient was prescribed Chloroquine Phosphate (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Methylprednisolone (methylprednisolone)
.After starting to take Chloroquine Phosphate the consumer reported adverse symptoms, such as: Bipolar Disorder, Major Depression, Mania, Suicidal Ideation, Systemic Lupus Erythematosus, Psychomotor Retardation, Feelings Of Worthlessness, Decreased InterestThese side effects may potentially be related to Chloroquine Phosphate. The patient was hospitalized.
Chloroquine Side Effect Report#9778671
Suicide Attempt, Coma, Overdose, Coma Scale Abnormal, Cardio-respiratory Arrest, Ventricular Fibrillation, Tachycardia, Hypoxia, Hypercapnia
This is a report of a 30-year-old male patient (weight: NA) from ES, suffering from the following health symptoms/conditions: prophylaxis,suicide attempt, who was treated with Chloroquine Phosphate (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Suicide Attempt, Coma, Overdose, Coma Scale Abnormal, Cardio-respiratory Arrest, Ventricular Fibrillation, Tachycardia, Hypoxia, Hypercapnia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Chloroquine Phosphate treatment in male patients, resulting in Suicide Attempt side effect. The patient was hospitalized.
Chloroquine Side Effect Report#9708494
Overdose, Cinchonism, Abdominal Pain, Vomiting, Intentional Self-injury, Hypotension, Blood Potassium Decreased, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram Qt Prolonged
This report suggests a potential Chloroquine Phosphate Overdose side effect(s) that can have serious consequences. A 44-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Chloroquine Phosphate (dosage: 250 Mg, 20 Pills Once) starting NS. After starting Chloroquine Phosphate the patient began experiencing various side effects, including: Overdose, Cinchonism, Abdominal Pain, Vomiting, Intentional Self-injury, Hypotension, Blood Potassium Decreased, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram Qt ProlongedAdditional drugs used concurrently: NA.The patient was hospitalized. Although Chloroquine Phosphate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Overdose, may still occur.
Chloroquine Side Effect Report#9699010
Intentional Self-injury, Abdominal Pain, Vomiting, Hypotension, Blood Potassium Decreased, Blood Magnesium Decreased, Electrocardiogram Pr Prolongation, Electrocardiogram Qrs Complex Prolonged, Cinchonism
This Intentional Self-injury problem was reported by a health professional from US. A 44-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Chloroquine (dosage: NA). The following drugs were being taken at the same time: NA. When using Chloroquine, the patient experienced the following unwanted symptoms/side effects: Intentional Self-injury, Abdominal Pain, Vomiting, Hypotension, Blood Potassium Decreased, Blood Magnesium Decreased, Electrocardiogram Pr Prolongation, Electrocardiogram Qrs Complex Prolonged, CinchonismAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Intentional Self-injury, may become evident only after a product is in use by the general population.
Chloroquine Side Effect Report#9696056
Malaria, Vomiting, Pyrexia, Chills, Dizziness, Cough, Nausea, Aphagia, Insomnia
This Malaria side effect was reported by a consumer or non-health professional from CN. A 20-year-old male patient (weight:NA) experienced the following symptoms/conditions: malaria.The patient was prescribed Chloroquine (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Primaquine
.After starting to take Chloroquine the consumer reported adverse symptoms, such as: Malaria, Vomiting, Pyrexia, Chills, Dizziness, Cough, Nausea, Aphagia, InsomniaThese side effects may potentially be related to Chloroquine. The patient was hospitalized.
Chloroquine Side Effect Report#9664651
Insomnia, Energy Increased, Suicidal Ideation, Nervousness, Crying, Delusion Of Grandeur, Hallucination, Auditory, Abnormal Behaviour, Confusional State
This is a report of a 39-year-old female patient (weight: NA) from TR, suffering from the following health symptoms/conditions: rheumatoid arthritis, who was treated with Chloroquine (dosage: NA, start time: NS), combined with:
  • Sulfasalazine (sulfasalazine)
and developed a serious reaction and side effect(s): Insomnia, Energy Increased, Suicidal Ideation, Nervousness, Crying, Delusion Of Grandeur, Hallucination, Auditory, Abnormal Behaviour, Confusional State after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Chloroquine treatment in female patients, resulting in Insomnia side effect. The patient was hospitalized.
Chloroquine Side Effect Report#9645348
Cinchonism, Intentional Overdose, Abdominal Pain, Vomiting, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram Qt Prolonged, Hypotension, Hypokalaemia
This report suggests a potential Chloroquine Phosphate Cinchonism side effect(s) that can have serious consequences. A 44-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: intentional self-injury and used Chloroquine Phosphate (dosage: 20 Tablets Of 250 Mg Each) starting NS. After starting Chloroquine Phosphate the patient began experiencing various side effects, including: Cinchonism, Intentional Overdose, Abdominal Pain, Vomiting, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram Qt Prolonged, Hypotension, HypokalaemiaAdditional drugs used concurrently: NA.The patient was hospitalized. Although Chloroquine Phosphate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Cinchonism, may still occur.
Chloroquine Side Effect Report#9631246
Retinal Pigment Epitheliopathy, Maculopathy, Toxicity To Various Agents
This Retinal Pigment Epitheliopathy problem was reported by a consumer or non-health professional from ES. A 34-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: systemic lupus erythematosus. On NS this consumer started treatment with Chloroquine (dosage: NA). The following drugs were being taken at the same time: NA. When using Chloroquine, the patient experienced the following unwanted symptoms/side effects: Retinal Pigment Epitheliopathy, Maculopathy, Toxicity To Various AgentsAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Retinal Pigment Epitheliopathy, may become evident only after a product is in use by the general population.
Chloroquine Side Effect Report#9602484
Depression, Overdose, 17 Ketosteroids Urine Decreased, Insomnia, Decreased Appetite, Decreased Interest, Depressed Mood, Suicidal Ideation, Depression
This Depression side effect was reported by a physician from IN. A 24-year-old male patient (weight:NA) experienced the following symptoms/conditions: malaria.The patient was prescribed Chloroquine (salt Not Specified) (drug dosage: NA), which was initiated on
Dec 10, 1976. Concurrently used drugs: NA..After starting to take Chloroquine (salt Not Specified) the consumer reported adverse symptoms, such as: Depression, Overdose, 17 Ketosteroids Urine Decreased, Insomnia, Decreased Appetite, Decreased Interest, Depressed Mood, Suicidal Ideation, DepressionThese side effects may potentially be related to Chloroquine (salt Not Specified). The patient was hospitalized.
Chloroquine Side Effect Report#9507644
Mania, Cerebral Atrophy, Cerebellar Atrophy, Arteriosclerosis, Cognitive Disorder, Disturbance In Attention
This is a report of a 72-year-old male patient (weight: NA) from SI, suffering from the following health symptoms/conditions: rheumatoid arthritis, who was treated with Chloroquine Phosphate (dosage: NA, start time: NS), combined with:
  • Etoricoxib
  • Gliquidone
  • Candesartan
  • Diltiazem (diltiazem) (diltiazem)
and developed a serious reaction and side effect(s): Mania, Cerebral Atrophy, Cerebellar Atrophy, Arteriosclerosis, Cognitive Disorder, Disturbance In Attention after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Chloroquine Phosphate treatment in male patients, resulting in Mania side effect. The patient was hospitalized.
Chloroquine Side Effect Report#9468225
Completed Suicide, Cardiac Disorder, Pulmonary Congestion, Flatulence, Toxicity To Various Agents
This report suggests a potential Chloroquine Completed Suicide side effect(s) that can have serious consequences. A 25-year-old female patient (weight: NA) from SZ was diagnosed with the following symptoms/conditions: NA and used Chloroquine (dosage: NA) starting NS. After starting Chloroquine the patient began experiencing various side effects, including: Completed Suicide, Cardiac Disorder, Pulmonary Congestion, Flatulence, Toxicity To Various AgentsAdditional drugs used concurrently:
  • Diazepam
  • Lorazepam
  • Paspertin (metocloramide)
  • Olazapine
  • Trimipramine
  • Paroxetine
Although Chloroquine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Completed Suicide, may still occur.
Chloroquine Side Effect Report#9447872
Urosepsis, Herpes Zoster, Off Label Use
This Urosepsis problem was reported by a health professional from PL. A 47-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: systemic lupus erythematosus. On NS this consumer started treatment with Chloroquine (salt Not Specified) (dosage: NA). The following drugs were being taken at the same time:
  • Hydroxychloroquine Sulfate
  • Mycophenolate Mofetil (1-2 G)
  • Prednisone
  • Prednisone
  • Cyclophosphamide
  • Corticosteroids
  • Immunoglobulin
  • Enoxaparin
When using Chloroquine (salt Not Specified), the patient experienced the following unwanted symptoms/side effects: Urosepsis, Herpes Zoster, Off Label UseAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Urosepsis, may become evident only after a product is in use by the general population.
Chloroquine Side Effect Report#9447868
Torsade De Pointes, Electrocardiogram Qt Shortened, Electrocardiogram Qt Prolonged, Ejection Fraction Decreased, Syncope
This Torsade De Pointes side effect was reported by a health professional from IN. A 63-year-old male patient (weight:NA) experienced the following symptoms/conditions: hepatic amoebiasis.The patient was prescribed Chloroquine (salt Not Specified) (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Chloroquine (salt Not Specified) the consumer reported adverse symptoms, such as: Torsade De Pointes, Electrocardiogram Qt Shortened, Electrocardiogram Qt Prolonged, Ejection Fraction Decreased, SyncopeThese side effects may potentially be related to Chloroquine (salt Not Specified). The patient was hospitalized.
Chloroquine Side Effect Report#9447661
Acquired Pigmented Retinopathy
This is a report of a 52-year-old female patient (weight: NA) from IN, suffering from the following health symptoms/conditions: sjogren^s syndrome, who was treated with Chloroquine (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Acquired Pigmented Retinopathy after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Chloroquine treatment in female patients, resulting in Acquired Pigmented Retinopathy side effect.
Chloroquine Side Effect Report#9437296
Cardiac Disorder, Conduction Disorder, Cardiac Failure, Cardiotoxicity, Ventricular Hypertrophy
This report suggests a potential Chloroquine Cardiac Disorder side effect(s) that can have serious consequences. A 59-year-old female patient (weight: NA) from ES was diagnosed with the following symptoms/conditions: cutaneous lupus erythematosus and used Chloroquine (dosage: (df) 25 Years) starting NS. After starting Chloroquine the patient began experiencing various side effects, including: Cardiac Disorder, Conduction Disorder, Cardiac Failure, Cardiotoxicity, Ventricular HypertrophyAdditional drugs used concurrently: NA. Although Chloroquine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Cardiac Disorder, may still occur.
Chloroquine Side Effect Report#9433291
Cardiomyopathy, Renal Failure Acute, Cardiac Failure Congestive, Atrioventricular Block
This Cardiomyopathy problem was reported by a physician from US. A 38-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: cutaneous lupus erythematosus. On NS this consumer started treatment with Chloroquine (watson Laboratories) (dosage: 500 Mg, Daily). The following drugs were being taken at the same time: NA. When using Chloroquine (watson Laboratories), the patient experienced the following unwanted symptoms/side effects: Cardiomyopathy, Renal Failure Acute, Cardiac Failure Congestive, Atrioventricular BlockAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cardiomyopathy, may become evident only after a product is in use by the general population.
Chloroquine Side Effect Report#9432576
Cardiomyopathy, Off Label Use, Ventricular Hypertrophy, Dyspnoea, Hyperdynamic Left Ventricle, Cardiac Murmur, Asthenia, Pulmonary Arterial Pressure Increased, Pulmonary Arterial Wedge Pressure Increased
This Cardiomyopathy side effect was reported by a physician from US. A 33-year-old female patient (weight:NA) experienced the following symptoms/conditions: systemic lupus erythematosus.The patient was prescribed Chloroquine Phosphate (drug dosage: NA), which was initiated on 1974. Concurrently used drugs:
  • Quinacrine
.After starting to take Chloroquine Phosphate the consumer reported adverse symptoms, such as: Cardiomyopathy, Off Label Use, Ventricular Hypertrophy, Dyspnoea, Hyperdynamic Left Ventricle, Cardiac Murmur, Asthenia, Pulmonary Arterial Pressure Increased, Pulmonary Arterial Wedge Pressure IncreasedThese side effects may potentially be related to Chloroquine Phosphate. The patient was hospitalized.
Chloroquine Side Effect Report#9432575
Cardiomyopathy, Off Label Use, Ventricular Hypertrophy, Cardiomegaly, Ventricular Fibrillation, Cardiac Arrest, Coma, Cyanosis, Hypotension
This is a report of a 73-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: systemic lupus erythematosus,cardiac failure congestive, who was treated with Chloroquine Phosphate (dosage: NA, start time: NS), combined with:
  • Digoxin
  • Diuretics
and developed a serious reaction and side effect(s): Cardiomyopathy, Off Label Use, Ventricular Hypertrophy, Cardiomegaly, Ventricular Fibrillation, Cardiac Arrest, Coma, Cyanosis, Hypotension after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Chloroquine Phosphate treatment in female patients, resulting in Cardiomyopathy side effect. The patient was hospitalized.


1 of 8 


The appearance of Chloroquine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.


Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Chloroquine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Chloroquine Side Effects

    Did You Have a Chloroquine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Chloroquine for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Chloroquine Safety Alerts, Active Ingredients, Usage Information

    NDC0115-2790
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameChloroquine Phosphate
    NameCHLOROQUINE PHOSPHATE
    Dosage FormTABLET
    RouteORAL
    On market since19741211
    LabelerGlobal Pharmaceuticals, Division of Impax Laboratories, Inc.
    Active Ingredient(s)CHLOROQUINE PHOSPHATE
    Strength(s)250
    Unit(s)mg/1
    Pharma ClassAntimalarial [EPC]

    Chloroquine Dosage, Warnings, Usage.

    Side Effects reported to FDA: 187

    Chloroquine safety alerts: No

    Reported deaths: 20

    Reported hospitalizations: 57

    Latest Chloroquine clinical trials